Neoleukin Therapeutics, Inc. (NLTX) - Balance Sheet Statement

Home
NLTX
Financials

3.49 (USD) • At close December 18, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	37.887	142.467	192.556	143.093	76.928	52.032	32.301	39.526	14.906	11.006	2.001
Short Term Investments Numbers are in millions	58.497	0	0	0	0	56.053	70.758	34.956	24.191	2.821	0
Cash and Short Term Investments Numbers are in millions	96.384	142.467	192.556	143.093	76.928	108.085	103.059	112.94	39.097	13.827	2.001
Net Receivables Numbers are in millions	0	0	0	0.503	0.237	0.74	0.426	0.032	0.065	0.028	0.029
Inventory Numbers are in millions	0	0	0	0	0	0	0	-0.032	0	0.064	0
Other Current Assets Numbers are in millions	2.75	1.522	1.966	0	0	0	0	0.314	0.139	1.377	0.035
Total Current Assets Numbers are in millions	99.134	143.989	194.522	143.596	77.165	108.825	103.485	113.254	39.302	15.296	2.064
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	15.878	17.218	13.724	2.83	0.4	0.905	0.849	0.089	0.105	0.075	0.158
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0.128	0.347	0.567	0	0	0	0	0	0.063	0.085
Goodwill and Intangible Assets Numbers are in millions	0	0.128	0.347	0.567	0	0	0	0	0	0.063	0.085
Long Term Investments Numbers are in millions	0	0	0	0	0	0	50.046	38.458	2.003	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.936	1.928	1.926	0.03	0.053	0.599	0	-38.458	0.013	0.215	0.035
Total Non-Current Assets Numbers are in millions	16.814	19.274	15.997	3.427	0.453	1.504	50.895	0.089	2.121	0.353	0.278
Total Assets Numbers are in millions	115.948	163.263	210.519	147.023	77.618	110.329	154.38	113.343	41.423	15.649	2.342
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	0.478	0.526	1.323	1.604	0.702	6.016	6.86	2.205	0.734	0.6	0.189
Short Term Debt Numbers are in millions	1.515	1.221	0.708	0.618	0	0	0	0	0	0.25	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	1.751	0
Other Current Liabilities Numbers are in millions	9.069	6.889	5.858	2.521	3.925	4.94	2.659	2.587	4.469	0.019	0.197
Total Current Liabilities Numbers are in millions	11.062	8.636	7.889	4.743	4.627	10.956	9.519	4.792	5.203	2.62	0.385
Non-Current Liabilities:
Long Term Debt Numbers are in millions	10.555	11.763	11.414	0.593	0.006	0.033	0.047	0	0	2.036	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0	0	0	0	0.313	0.453	0.15	0.131	0.072	0.23	53.058
Total Non-Current Liabilities Numbers are in millions	10.555	11.763	11.414	0.593	0.319	0.486	0.197	0.131	0.072	2.266	53.058
Total Liabilities Numbers are in millions	21.617	20.399	19.303	5.336	4.946	11.442	9.716	4.923	5.276	4.887	53.443
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0.535
Retained Earnings Numbers are in millions	-451.055	-393.498	-332.806	-299.529	-230.087	-198.502	-148.278	-111.276	-89.416	-63.631	-51.636
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0.021	0	0	0	-0.443	-0.07	-0.169	-0.29	-0.004	-0.253	-0.395
Other Total Stockholders Equity Numbers are in millions	545.407	536.362	524.022	441.216	303.202	297.459	293.111	219.986	125.841	74.646	0.395
Total Shareholders Equity Numbers are in millions	94.331	142.864	191.216	141.687	72.672	98.887	144.664	108.42	36.147	10.763	-51.101
Total Equity Numbers are in millions	94.331	142.864	191.216	141.687	72.672	98.887	144.664	108.42	36.147	10.763	-51.101
Total Liabilities & Shareholders Equity Numbers are in millions	115.948	163.263	210.519	147.023	77.618	110.329	154.38	113.343	41.423	15.649	2.342

Neoleukin Therapeutics, Inc.

NASDAQ:NLTX Add to watchlist

NASDAQ:NLTX